ZYTER, INC. – Trademark Portfolio
Entity Type: 03
ZYTER, INC. holds 41 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 34 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 11 trademarks are registered and 22 are pending. Notable registered marks include ZYTER, CASENET, TRUCARE, ZYTERHOME, and ZYTER TRUCARE. The owner is based in ROCKVILLE, MD.
2600 TOWER OAKS BLVD.
SUITE 700
ROCKVILLE, MD 20852
Showing of trademarks Trademarks
Trademark Classifications
ZYTER, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does ZYTER, INC. have?
ZYTER, INC. has 41 U.S. trademarks filed with the USPTO. Of these, 11 registered, 22 pending, 3 abandoned, 5 cancelled.
What trademark classes does ZYTER, INC. file in?
ZYTER, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are ZYTER, INC.'s most well-known trademarks?
ZYTER, INC.'s registered trademark portfolio includes well-known marks such as ZYTER, CASENET, TRUCARE, ZYTERHOME, and ZYTER TRUCARE. These are among 11 currently registered trademarks in the portfolio.
What is ZYTER, INC.'s trademark registration success rate?
ZYTER, INC. has a 58% trademark registration rate, with 11 out of 19 resolved applications resulting in successful registration. Currently, 22 applications are pending review.